Rippy John T
Known title: EVP, Chief Risk OfficerCIK: 0001632077
Associated companies
Transaction History
| RBCAA | ▲ Buy | Grant | 137 | $10K | 6/30/2025 | View on chart |
| RBCAA | ▲ Buy | Option Exercise | 5,376 | $230K | 4/25/2025 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 4,316 | $289K | 4/25/2025 | View on chart |
| RBCAA | ▲ Buy | Option Exercise | 4,484 | $221K | 4/25/2025 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 3,837 | $257K | 4/25/2025 | View on chart |
| RBCAA | ▲ Buy | Grant | 1,774 | $108K | 4/8/2025 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 808 | $49K | 4/8/2025 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 211 | $14K | 4/2/2025 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 436 | $28K | 4/2/2025 | View on chart |
| RBCAA | ▲ Buy | Grant | 188 | $12K | 3/31/2025 | View on chart |
| RBCAA | ▲ Buy | Option Exercise | 1,500 | $54K | 3/10/2025 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 832 | $55K | 3/10/2025 | View on chart |
| RBCAA | ▼ Sell | Open Market | 3,082 | $203K | 1/30/2025 | View on chart |
| RBCAA | ▲ Buy | Grant | 957 | $0 | 1/15/2025 | View on chart |
| RBCAA | ▲ Buy | Option Exercise | 4,868 | $250K | 1/13/2025 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 4,364 | $284K | 1/13/2025 | View on chart |
| RBCAA | ▲ Buy | Grant | 96 | $7K | 12/31/2024 | View on chart |
| RBCAA | ▲ Buy | Grant | 881 | $62K | 12/31/2024 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 304 | $21K | 12/31/2024 | View on chart |
| RBCAA | ▲ Buy | Grant | 88 | $6K | 9/30/2024 | View on chart |
| RBCAA | ▲ Buy | Option Exercise | 1,500 | $54K | 7/29/2024 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 833 | $54K | 7/29/2024 | View on chart |
| RBCAA | ▲ Buy | Grant | 126 | $7K | 6/28/2024 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 571 | $29K | 3/30/2024 | View on chart |
| RBCAA | ▲ Buy | Grant | 113 | $6K | 3/29/2024 | View on chart |
| RBCAA | ▲ Buy | Grant | 476 | $23K | 1/16/2024 | View on chart |
| RBCAA | ▲ Buy | Option Exercise | 5,000 | $181K | 1/1/2024 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 4,160 | $229K | 1/1/2024 | View on chart |
| RBCAA | ▲ Buy | Grant | 617 | $34K | 12/31/2023 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 614 | $34K | 12/31/2023 | View on chart |
| RBCAA | ▲ Buy | Grant | 122 | $7K | 12/29/2023 | View on chart |
| RBCAA | ▲ Buy | Grant | 131 | $6K | 9/29/2023 | View on chart |
| RBCAA | ▲ Buy | Grant | 158 | $7K | 6/30/2023 | View on chart |
| RBCAA | ▲ Buy | Grant | 136 | $6K | 3/31/2023 | View on chart |
| RBCAA | ▼ Sell | Tax Withholding | 317 | $13K | 3/30/2023 | View on chart |
| RBCAA | ▲ Buy | Grant | 422 | $17K | 12/31/2022 | View on chart |
| RBCAA | ▲ Buy | Grant | 158 | $6K | 12/30/2022 | View on chart |
| RBCAA | ▲ Buy | Grant | 178 | $7K | 9/30/2022 | View on chart |
| RBCAA | ▲ Buy | Grant | 121 | $6K | 6/30/2022 | View on chart |
| RBCAA | ▲ Buy | Grant | 130 | $6K | 3/31/2022 | View on chart |
| RBCAA | ▲ Buy | Grant | 667 | $34K | 1/18/2022 | View on chart |
| RBCAA | ▲ Buy | Grant | 127 | $6K | 12/31/2021 | View on chart |
| RBCAA | ▲ Buy | Grant | 135 | $7K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
RBCAA featured in dividend roundup and questioned fundamentals
RBCAA appeared in Seeking Alpha’s “Dividend Champion, Contender, And Challenger Highlights” for the week of October 11, noting its 3.15% dividend yield. The same stock was also listed by Yahoo as one of three “Unpopular Stocks with Questionable Fundamentals,” suggesting concerns about its financial health. The contrasting coverage highlights both the appeal of its dividend and the scrutiny of its fundamentals.
RBCAA featured in dividend roundup and questioned fundamentals. RBCAA appeared in Seeking Alpha’s “Dividend Champion, Contender, And Challenger Highlights” for the week of October 11, noting its 3.15% dividend yield. The same stock was also listed by Yahoo as one of three “Unpopular Stocks with Questionable Fundamentals,” suggesting concerns about its financial health. The contrasting coverage highlights both the appeal of its dividend and the scrutiny of its fundamentals.